Display options
Cite
Mikhaylenko DS, Klimov AV, Matveev VB, et al. Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline . Front Oncol. 2020;9:1566doi: 10.3389/fonc.2019.01566.
Mikhaylenko, D. S., Klimov, A. V., Matveev, V. B., Samoylova, S. I., Strelnikov, V. V., Zaletaev, D. V., Lubchenko, L. N., Alekseev, B. Y., & Nemtsova, M. V. (2019). Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline . Frontiers in oncology, 91566. https://doi.org/10.3389/fonc.2019.01566
Mikhaylenko, Dmitry S, et al. "Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline ." Frontiers in oncology vol. 9 (2019): 1566. doi: https://doi.org/10.3389/fonc.2019.01566
Mikhaylenko DS, Klimov AV, Matveev VB, Samoylova SI, Strelnikov VV, Zaletaev DV, Lubchenko LN, Alekseev BY, Nemtsova MV. Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline . Front Oncol. 2020 Jan 21;9:1566. doi: 10.3389/fonc.2019.01566. eCollection 2019. PMID: 32039030; PMCID: PMC6985093.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2020 Jan 21;9:1566. doi: 10.3389/fonc.2019.01566. eCollection 2019.

Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline .

Frontiers in oncology

Dmitry S Mikhaylenko, Alexey V Klimov, Vsevolod B Matveev, Svetlana I Samoylova, Vladimir V Strelnikov, Dmitry V Zaletaev, Ludmila N Lubchenko, Boris Y Alekseev, Marina V Nemtsova

Affiliations

  1. Laboratory of Medical Genetics, Institute of Molecular Medicine, Scientific Biotechnological Park of Biomedicine, Sechenov University, Moscow, Russia.
  2. Laboratory of Pathology and Molecular Genetics, N. Lopatkin Institute of Urology and Interventional Radiology - Branch of the National Medical Research Center of Radiology, Moscow, Russia.
  3. Laboratory of Epigenetics, Research Centre for Medical Genetics Named After Academician N. P. Bochkov, Moscow, Russia.
  4. Department of Urology, Institute of Clinical Oncology, N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.

PMID: 32039030 PMCID: PMC6985093 DOI: 10.3389/fonc.2019.01566

Abstract

Hereditary papillary renal carcinoma (HPRC) is a rare autosomal dominant disease characterized by the development of multiple papillary type I renal cell carcinomas. This hereditary kidney cancer form is caused by activating mutations in

Copyright © 2020 Mikhaylenko, Klimov, Matveev, Samoylova, Strelnikov, Zaletaev, Lubchenko, Alekseev and Nemtsova.

Keywords: MET gene; germline mutation; hereditary cancer syndrome; kidney cancer; papillary renal cell carcinoma

References

  1. World J Urol. 2018 Dec;36(12):1891-1898 - PubMed
  2. Cell Rep. 2016 Mar 15;14(10):2476-89 - PubMed
  3. Int J Cancer. 1999 Aug 27;82(5):640-3 - PubMed
  4. Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60 - PubMed
  5. Int J Urol. 2019 Sep;26(9):868-877 - PubMed
  6. Kidney Cancer. 2019 Nov 01;3(3):151-161 - PubMed
  7. Urologia. 2019 Feb;86(1):3-8 - PubMed
  8. Acta Oncol. 2019 Mar;58(3):306-312 - PubMed
  9. Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19936-41 - PubMed
  10. Onco Targets Ther. 2014 Jun 12;7:1001-14 - PubMed
  11. Nat Genet. 1997 May;16(1):68-73 - PubMed
  12. Nat Commun. 2015 Mar 19;6:6336 - PubMed
  13. N Engl J Med. 2016 Jan 14;374(2):135-45 - PubMed
  14. Eur Urol. 2019 Dec;76(6):754-764 - PubMed
  15. Crit Rev Oncol Hematol. 2015 Oct;96(1):100-12 - PubMed
  16. Clin Cancer Res. 2014 Jul 1;20(13):3411-21 - PubMed
  17. Cancers (Basel). 2014 Dec 16;6(4):2387-403 - PubMed
  18. Fam Cancer. 2012 Sep;11(3):535-7 - PubMed
  19. Cancer Discov. 2019 Aug;9(8):1006-1021 - PubMed
  20. Nat Genet. 2015 Jan;47(1):13-21 - PubMed
  21. Ann Transl Med. 2017 May;5(10):205 - PubMed
  22. CA Cancer J Clin. 2018 Nov;68(6):394-424 - PubMed

Publication Types